Fuller & Thaler Asset Management’s Charles River Laboratories CRL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $67.6M | Buy |
+445,808
| New | +$67.6M | 0.25% | 147 |
|
2022
Q1 | – | Sell |
-72
| Closed | -$27K | – | 493 |
|
2021
Q4 | $27K | Hold |
72
| – | – | ﹤0.01% | 476 |
|
2021
Q3 | $30K | Hold |
72
| – | – | ﹤0.01% | 455 |
|
2021
Q2 | $27K | Sell |
72
-80
| -53% | -$30K | ﹤0.01% | 457 |
|
2021
Q1 | $44K | Hold |
152
| – | – | ﹤0.01% | 456 |
|
2020
Q4 | $38K | Hold |
152
| – | – | ﹤0.01% | 452 |
|
2020
Q3 | $34K | Hold |
152
| – | – | ﹤0.01% | 454 |
|
2020
Q2 | $27K | Hold |
152
| – | – | ﹤0.01% | 442 |
|
2020
Q1 | $19K | Sell |
152
-3
| -2% | -$375 | ﹤0.01% | 439 |
|
2019
Q4 | $24K | Hold |
155
| – | – | ﹤0.01% | 425 |
|
2019
Q3 | $21K | Hold |
155
| – | – | ﹤0.01% | 433 |
|
2019
Q2 | $22K | Hold |
155
| – | – | ﹤0.01% | 422 |
|
2019
Q1 | $23K | Hold |
155
| – | – | ﹤0.01% | 403 |
|
2018
Q4 | $18K | Hold |
155
| – | – | ﹤0.01% | 413 |
|
2018
Q3 | $21K | Hold |
155
| – | – | ﹤0.01% | 399 |
|
2018
Q2 | $17K | Hold |
155
| – | – | ﹤0.01% | 728 |
|
2018
Q1 | $17K | Buy |
+155
| New | +$17K | ﹤0.01% | 725 |
|
2016
Q1 | – | Sell |
-500
| Closed | -$40K | – | 783 |
|
2015
Q4 | $40K | Hold |
500
| – | – | ﹤0.01% | 667 |
|
2015
Q3 | $32K | Buy |
+500
| New | +$32K | ﹤0.01% | 618 |
|